List of works - Tarek M Meniawy

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis

scientific article published on 8 January 2016

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy

scientific article published on 16 October 2020

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

scientific article published on 22 September 2015

Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma

scientific article published on 02 November 2019

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

scientific article

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

scientific article published on 9 July 2018

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma

scientific article published on 27 August 2013

Ipilimumab- and nivolumab-associated enterocolitis with florid necrotising granulomatous inflammation: a novel manifestation of 'immunomodulatory' enterocolitis

scientific article published on 04 May 2018

Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device.

scientific article published on 27 June 2017

Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?

scientific article published on 11 October 2019

Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA (ctDNA) in metastatic melanoma

scientific article published on 07 December 2018

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies

scientific article published on 04 January 2019

PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors

scientific article published on 30 December 2015

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

scientific article published on 01 August 2019

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data

scientific article published on 19 May 2019

Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer

scientific article published on 18 December 2018

Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma.

scientific article published in May 2017

Response to comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'.

scientific article published on 8 April 2014

Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion

scientific article published on 07 November 2019

Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma

scientific article published on 18 August 2017

The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond <i>BRAF</i> Mutant Detection

scientific article published on 16 December 2020

List of works by Tarek M Meniawy